Digital technologies for delivering multidisciplinary weight-management services: early value assessment (HTE14)Product type:GuidanceProgramme:Health technology evaluationLast updated: 6 March 2024Published: 26 October 2023
Semaglutide for managing overweight and obesity (TA875)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 4 September 2023Published: 8 March 2023
Obesity: identification, assessment and management (CG189)Product type:GuidanceProgramme:Clinical guidelineLast updated: 26 July 2023Published: 27 November 2014
Semaglutide for managing overweight and obesity in young people aged 12 to 17 years (terminated appraisal) (TA910)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 July 2023
Liraglutide for managing obesity in people aged 12 to 17 years (terminated appraisal) (TA749)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 December 2021
Liraglutide for managing overweight and obesity (TA664)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 9 December 2020
Swallowable gastric balloon capsule for weight loss (IPG684)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 18 November 2020
Neonatal parenteral nutrition (NG154)Product type:GuidanceProgramme:NICE guidelinePublished: 26 February 2020
Naltrexone–bupropion for managing overweight and obesity (TA494)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 12 December 2017
Vitamin D: supplement use in specific population groups (PH56)Product type:GuidanceProgramme:Public health guidelineLast updated: 30 August 2017Published: 26 November 2014
Nutrition support for adults: oral nutrition support, enteral tube feeding and parenteral nutrition (CG32)Product type:GuidanceProgramme:Clinical guidelineLast updated: 4 August 2017Published: 22 February 2006
Dementia, disability and frailty in later life – mid-life approaches to delay or prevent onset (NG16)Product type:GuidanceProgramme:NICE guidelinePublished: 20 October 2015
Obesity prevention (CG43)Product type:GuidanceProgramme:Clinical guidelineLast updated: 13 March 2015Published: 13 December 2006
Preventing excess weight gain (NG7)Product type:GuidanceProgramme:NICE guidelinePublished: 13 March 2015
Maternal and child nutrition (PH11)Product type:GuidanceProgramme:Public health guidelineLast updated: 1 November 2014Published: 26 March 2008
Weight management: lifestyle services for overweight or obese adults (PH53)Product type:GuidanceProgramme:Public health guidelinePublished: 28 May 2014
Behaviour change: individual approaches (PH49)Product type:GuidanceProgramme:Public health guidelinePublished: 2 January 2014
Implantation of a duodenal–jejunal bypass sleeve for managing obesity (IPG471)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 November 2013
Weight management: lifestyle services for overweight or obese children and young people (PH47)Product type:GuidanceProgramme:Public health guidelinePublished: 23 October 2013
Weight management before, during and after pregnancy (PH27)Product type:GuidanceProgramme:Public health guidelinePublished: 28 July 2010
Cardiovascular disease prevention (PH25)Product type:GuidanceProgramme:Public health guidelinePublished: 22 June 2010
Behaviour change: general approaches (PH6)Product type:GuidanceProgramme:Public health guidelinePublished: 24 October 2007
CORTRAK 2 Enteral Access System for placing nasoenteral feeding tubes (MIB48)Product type:AdviceProgramme:Medtech innovation briefingLast updated: 9 December 2016Published: 22 January 2016
Promoting health and preventing premature mortality in black, Asian and other minority ethnic groups (QS167)Product type:Quality standardPublished: 11 May 2018
Obesity: clinical assessment and management (QS127)Product type:Quality standardPublished: 4 August 2016
Obesity in adults: prevention and lifestyle weight management programmes (QS111)Product type:Quality standardPublished: 19 January 2016
Obesity in children and young people: prevention and lifestyle weight management programmes (QS94)Product type:Quality standardPublished: 23 July 2015
Nutrition: improving maternal and child nutrition (QS98)Product type:Quality standardPublished: 1 July 2015
Tirzepatide for managing overweight and obesity [ID6179]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 23 December 2024
Overweight and obesity managementStatus:In developmentProgramme:NICE guidelineExpected publication date: 14 January 2025
Maternal and child nutritionStatus:In developmentProgramme:NICE guidelineExpected publication date: 15 January 2025
Oral semaglutide for managing overweight and obesity [ID6188]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Setmelanotide for treating obesity caused by a rare genetic disorder in children aged 2 to 5 TS ID 11827Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Setmelanotide for treating acquired hypothalamic obesity in people 4 years and older TSID 11995Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC